Nordea Investment Management AB Grows Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Nordea Investment Management AB increased its stake in HCA Healthcare by 6.8%, acquiring 59,163 additional shares, bringing its total holdings to approximately $350 million.
• HCA Healthcare reported impressive quarterly earnings, with an EPS of $6.84, surpassing estimates and reflecting a 6.4% year-over-year revenue increase to $18.61 billion.
• The company declared a quarterly dividend of $0.72 per share, which equates to an annualized yield of 0.7% and a payout ratio of just over 12%.

Nordea Investment Management AB boosted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 6.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 927,781 shares of the company's stock after buying an additional 59,163 shares during the quarter. Nordea Investment Management AB owned approximately 0.39% of HCA Healthcare worth $350,404,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare in the first quarter worth $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the first quarter valued at $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare during the first quarter valued at $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the second quarter valued at $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare during the second quarter valued at $27,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Down 0.2%

HCA opened at $419.53 on Friday. The company has a market cap of $98.17 billion, a P/E ratio of 17.63, a P/E/G ratio of 1.33 and a beta of 1.40. The business's 50-day moving average price is $409.17 and its 200-day moving average price is $377.66. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the business earned $5.50 earnings per share. The company's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. The Goldman Sachs Group assumed coverage on HCA Healthcare in a research note on Tuesday. They set a "buy" rating and a $470.00 price objective for the company. Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a research note on Thursday, September 18th. KeyCorp lifted their price target on HCA Healthcare from $370.00 to $465.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Finally, Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $431.07.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.